Cinnamoyl, p-coumaroyl, feruloyl, caŠeoyl aloesin, and related compounds were isolated from Aloe species. The antiin‰ammatory and antioxidative activities of these compounds were examined based on the structure-activity relationship. It was suggested that the bioactivities may link to acyl ester groups in aloesin, together with those of aloesin-related compounds. However, investigations using the contact hypersensitivity response indicated a preventive eŠect of aloesin on the UV B-induced immune suppression. Furthermore, aloesin inhibited tyrosine hydroxylase and dihydroxyphenylalanine (DOPA) oxidase activities of tyrosinase from normal human melanocyte cell lysates. These results show that aloesin prevents not only UV B-induced immune suppression, but also could be a positive pigmentaltering agent for cosmetic application. In preclinical study, aloe extract was investigated using phagocytosis and nitroblue tetrazolium chloride (NBT) reduction in adult bronchial asthma, and high molecular-weight materials, such as polysaccharide and glycoprotein fractions, were identiˆed as active ingredients. The neutral polysaccharides, aloemannan and acemannan showed antitumor, antiin‰ammatory and immunosuppressive activities, and glycoprotein fractions with bradykinindegrading and cell proliferation-stimulating activities were identiˆed from the nondialysate fraction of the gel part of Aloe species. Verectin fractionated from Aloe vera gel was examined biochemically and immunochemically, and verectin antibody was used in the appraisal of commercial Aloe vera gel products. It was reported that aloesin stimulates the proliferation of cultured human hepatoma SK Hep 1 cells. Thus aloesin, related compounds, and high molecularweight materials, such as aloemannan and verectin, may act in concert to exert therapeutic properties for wounds, burns and in‰ammation. The biodisposition of ‰uoresceinylisothiocyanate (FITC)-labeled aloemannan (FITC AM) with the homogenate from some organs in mice was demonstrated, and FITC AM was metabolized to a smaller molecule (MW 3000) by the large intestinal micro‰ora in feces. The modiˆed aloe polysaccharide (MW: 80000) with cellulase under restricted conditions, immunologically stimulated the recovery of UV B-induced tissue in jury. Thus the modiˆed polysaccharides of aloemannan, together with acemannan (MW: about 600000), are expected to participate in biological activity following oral administration. The eŠects of tanshinone VI, a diterpenoid isolated from Salvia miltiorrhiza, on the heart are reviewed. First, the eŠects on the posthypoxic recovery of contractile function of perfused rat hearts were examined. Hypoxia/reoxygenation induced a release of purine nucleosides and bases (ATP metabolites) and resulted in little recovery of contractile force of reoxygenated hearts. Pretreatment of the perfused heart with 42 nM tanshinone VI under hypoxic conditions attenuated the release of ATP metabolites during hypoxia/reoxygenation. Treatment with tanshinone VI enhanced the posthypoxic recovery of myocardial contractility. These results show that tanshinone VI may protect the heart against hypoxia/reoxygenation injury and improve the posthypoxic cardiac function. Second, the eŠects of tanshinone VI on in vitro myocardial remodeling were examined. Cardiomyocytes and cardiaĉ broblasts were isolated from neonatal rat hearts, and simultaneously prepared insulin-like growth factor-1 (IGF 1) induced the hypertrophy of cardiomyocytes. IGF 1 increased the collagen synthesis of cardiacˆbroblasts, that is, in vitrô brosis. The hypertrophy of cardiomyocytes was attenuated in the presence of tanshinone VI in the culture medium. Thê brosis of cardiacˆbroblasts was decreased by treatment with tanshinone VI. When tanshinone VI was added to cardiaĉ broblast-conditioned medium, the medium-mediated hypertrophy of cardiomyocytes was also attenuated. These
results show that tanshinone VI may attenuate in vitro cardiac remodeling. The series of studies has shown that tanshinone VI protects the myocardium against hypoxia/reoxygenation injury and attenuates progression of in vitro myocardial remodeling, suggesting that tanshinone VI is a possible agent for the treatment of cardiac disease with contractile failure. A summary of results from in vitro (mushroom), cell lysate (human melanocytes) and in situ (murine) assays. a) Mushroom: One unit tyrosinase activity＝DA280 of 0.001 per min at pH 6.5 at 25°in 3 ml reaction mix containing L -tyrosine (Sigma Chemical Co.), b) Murine B16 melanoma cells (ATCC # CRL 6323), c) Human primary melanocytes (lysate), African-American donor (University of Cincinnati). Aloesin applied in aˆnite dose to human cadaver skin. Results for cumulative penetration in 32 h are shown.
Fig. 2. Anti-tyrosinase Activity
A: Inhibitory action of compounds 1-3, aloesin, p-coumoroylaloesin and ascorbic acids against tyrosine oxidation by mushroom tyrosinase. B: Inhibitory action of compounds 6-13 and ascorbic acid against tyrosine oxidation by mushroom tyrosinase.
Fig. 3. EŠect of Aloesin on Melanin Formation In Situ
Murine melanoma cells were treated with aloesin forˆve days. Melanin production was stimulated with a-MSH.
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Vol. a) The compounds were tested at a maximum concentration of 100 mM and DMSO was used as a solvent for the assay. Five ml of the solution in which aloe extract was dissolved at a concentration of 20 with saline, was administered twice a day for six months. Vol. 123 (2003) CDC25A の蛋白レベルがコントロールされている ことを示した( Fig. 4 ) ． 23) アロエシンにヒト肝 SK 
Fig. 10. EŠect of Tanshinone VI on Changes in Resting Tension of Hypoxic/Reoxygenated Hearts
Perfused rat hearts treated with (○)and without 42 nM tanshinone VI (•)were subjected to 20-min hypoxia/45-min reoxgenation. For the purpose of comparion, hearts treated with (△)and without (▲)tanshinone VI were perfused under normoxic conditions. The initial value for the resting tension of perfused hearts was adjusted to 1.5 g (n＝40). Each value represents the mean±SEM of 10 experiments. Statistical signiˆcance was calculated at the end of hypoxia/reoxygenation. There were no signiˆcant diŠerences in the resting tension between tanshinone VI-treated and untreated groups. 
